Home.md
... ...
@@ -10,11 +10,11 @@ To get started, select one of the gene lists from the table below then select th
10 10
11 11
**Tier 2** - Any gene described as significantly or recurrently mutated in one or more types of B-cell lymphoma is initially assigned to Tier 2 for that entity. The study describing the mutation of that gene in a particular entity is considered the originating study.
12 12
13
-**Tier 1** Genes can transition to Tier 1 only after additional studies have demonstrated the recurrence of mutations in the same entity.
13
+**Tier 1** - Genes can transition to Tier 1 only after additional studies have demonstrated the recurrence of mutations in the same entity.
14 14
15 15
### Gene Designations
16 16
17
-**aSHM** Denotes genes documented as being affected by aberrant somatic hypermutation (aSHM). Tier 1 and Tier 2 genes can have this designation, respectively abbreviated as *1-a* and *2-a*. For example, see [BCL7A](BCL7A).
17
+**aSHM** - Denotes genes documented as being affected by aberrant somatic hypermutation (aSHM). Tier 1 and Tier 2 genes can have this designation, respectively abbreviated as *1-a* and *2-a*. For example, see [BCL7A](BCL7A).
18 18
19 19
```mermaid
20 20
---